Watson garners 24% increase in Q2 sales
PARSIPPANY, N.J. — Watson Pharmaceuticals had sales of $1.1 billion during second quarter 2011, the generic drug maker said.
In a financial report released Tuesday, Watson said the sales figures for the quarter represented a 24% increase over sales in second quarter 2010. Profit for the quarter was $52.4 million, compared with $70.6 million in second quarter 2010.
“Our record $1 billion in net revenues in the second quarter demonstrates the strength of our combined global generics and global brands strategies,” Watson president and CEO Paul Bisaro said.
Lupin seeks to market generic Lo Loestrin Fe
NEW YORK — Generic drug maker Lupin is seeking approval for a generic version of a contraceptive made by Warner Chilcott, according to published reports.
Reuters reported that Lupin had applied for approval of a generic version of Lo Loestrin Fe (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate tablets), an oral contraceptive.
The Food and Drug Administration approved Lo Loestrin Fe in October 2010, and it’s covered by patents set to expire in July 2014 and February 2029, according to the FDA. Warner Chilcott expects to file a patent infringement suit against Lupin, according to Reuters.
Supplylogix inks deal with Midwest healthcare provider
GRAPEVINE, Texas — Healthcare technology company Supplylogix has signed an agreement with an unnamed healthcare provider in the Midwest to provide pharmaceutical inventory management and demand forecasting.
Supplylogix will provide the services for the provider’s 80 pharmacies and central-fill facility, and the provider recently completed a 45-day full deployment of the company’s services.
“Our ability to offer the level of control our clients require to manage pharmaceutical inventory, as well as optimize for specific demand as prescriptions shift between community pharmacies and central fill, was key to earning this business,” Supplylogix president and CEO Mark Wilgus said. “This client is a widely respected provider of health care within their communities, and we look forward to helping them serve their pharmacy patients and drive new efficiencies in their pharmacy operations.”